, Tracking Stock Market Picks
Enter Symbol:
Akebia Therapeutics Inc. (AKBA) [hlAlert]

down 15.86 %

Akebia Therapeutics Inc. (AKBA) rated Buy with price target $18 by Needham

Posted on: Tuesday,  Dec 15, 2015  8:25 AM ET by Needham

Needham rated Buy Akebia Therapeutics Inc. (NASDAQ: AKBA) on 12/15/2015. Previously Needham rated Buy Akebia Therapeutics Inc. (NASDAQ: AKBA) on 05/11/2015.,
when the stock price was $7.69. Since then, Akebia Therapeutics Inc. has lost 15.86% as of 12/15/2015's recent price of $6.47.
If you would have followed the previous Needham's recommendation on AKBA, you would have lost 15.86% of your investment in 218 days.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2015 8:25 AM Buy
10.85 18.00
as of 8/27/2015
1 Week down  -30.43 %
1 Month down  -33.29 %
3 Months down  -19.62 %
1 YTD down  -15.86 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/11/2015 8:25 AM Buy
7.69 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy